Parmax Pharma

{
  "main_header": {
    "sid": 1002724,
    "name": "Parmax Pharma",
    "stock_name": "Parmax Pharma",
    "full_name": "Parmax Pharma Ltd",
    "name_url": "stocks-analysis/parmax-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "111.00",
    "chg": 2.15,
    "chgp": "1.98%",
    "dir": 1,
    "prev_price": "108.85",
    "mcapval": "41.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540359,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE240T01014",
    "curr_date": "Aug 11, 03:30 PM",
    "curr_time": "07:06 AM",
    "last_traded_at": "Aug 11, 03:30 PM IST",
    "bse_nse_vol": "151 ",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parmax-pharma-1002724-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parmax Pharma Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parmax-pharma-downgraded-to-strong-sell-amid-mixed-technicals-and-weak-fundamentals-4139391",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ParmaxPharmaLtd_mojoScore_4139391.png",
        "date": "2026-08-06 08:31:34",
        "description": "Parmax Pharma Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 5 August 2026, reflecting a complex interplay of deteriorating financial fundamentals, challenging valuation metrics, and mixed technical signals. Despite a robust stock price performance over the past year, the company’s underlying financial health and operational trends have raised significant concerns among analysts."
      },
      {
        "title": "Parmax Pharma Gains 1.90%: 2 Key Milestones Mark a Week of Strong Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-gains-190-2-key-milestones-mark-a-week-of-strong-momentum-4131513",
        "imagepath": "",
        "date": "2026-08-01 13:06:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens week at Rs.104.87, gaining 1.98%</p>\n                    <p><strong>28 Jul:</strong> Continued gains to Rs.106.96 (+1.99%) despite Sensex dip</p>\n                    <p><strong>29 Jul:</strong> Stock rises to Rs.109.09 (+1.99%) with Sensex recovery</p>\n                    <p><strong>30 Jul:</strong> Parmax Pharma hits new 52-week and all-time high at Rs.111.27</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.104.78, retreating 1.99% from peak</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.102.83</div></d..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 111.27",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs11127-4128642",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParmaxPharmaLtd_priceRelatedfactors_4128642.png",
        "date": "2026-07-30 10:36:26",
        "description": "From a low of Rs 22.60 to a fresh peak of Rs 111.27, Parmax Pharma Ltd has surged an impressive 193.36% over the past year, significantly outperforming the Sensex which declined 4.77% in the same period. This remarkable rally culminated in the stock hitting a new 52-week and all-time high on 30 Jul 2026, fuelled by a confluence of strong technical signals and sustained price momentum."
      },
      {
        "title": "Parmax Pharma Ltd Hits All-Time High of Rs 111.27 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-stock-hits-all-time-high-of-rs11127-on-30-jul-2026-4128632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParmaxPharmaLtd_priceRelatedfactors_4128632.png",
        "date": "2026-07-30 10:32:37",
        "description": "Extending its winning streak to four consecutive sessions, Parmax Pharma Ltd surged 2.00% today to touch a fresh all-time high of Rs 111.27, significantly outpacing the Sensex which declined 0.15% in the same period."
      },
      {
        "title": "Parmax Pharma Gains 1.90%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-gains-190-5-key-factors-driving-the-weeks-momentum-4120505",
        "imagepath": "",
        "date": "2026-07-25 13:03:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> New 52-week and all-time high at Rs.102.92</p>\n                    <p><strong>21 Jul:</strong> Stock surged to Rs.104.97, marking another all-time high</p>\n                    <p><strong>22 Jul:</strong> New 52-week high of Rs.107.06 amid market weakness</p>\n                    <p><strong>23 Jul:</strong> Peak at Rs.109.20 before closing lower</p>\n                    <p><strong>24 Jul:</strong> Week closes at Rs.102.83, down 1.99% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.100.91</div></div>\n                    <div class..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 109.2",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs1092-4117799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParmaxPharmaLtd_priceRelatedfactors_4117799.png",
        "date": "2026-07-23 10:46:10",
        "description": "Surging to an all-time high of Rs 109.2 on 23 Jul 2026, Parmax Pharma Ltd has demonstrated remarkable momentum, rallying over 51% in the past 21 trading sessions. This micro-cap pharmaceutical stock’s ascent comes amid a broader market that remains subdued, with the Sensex trading slightly lower, underscoring the stock’s standout performance in its sector."
      },
      {
        "title": "Parmax Pharma Ltd Hits All-Time High of Rs 109.20 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-stock-hits-all-time-high-at-rs10920-4117773",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParmaxPharmaLtd_priceRelatedfactors_4117773.png",
        "date": "2026-07-23 10:33:22",
        "description": "Extending a remarkable winning streak to 21 sessions, Parmax Pharma Ltd surged to a fresh all-time high of Rs 109.20 on 23 Jul 2026, outperforming the Sensex which declined 0.15% on the day. The stock’s 51.31% return over the past month and 222.79% year-to-date gain highlight a strong momentum that has captured market attention."
      },
      {
        "title": "Parmax Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parmax-pharma-ltd-is-rated-sell-4117541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParmaxPharmaLtd_mojoScore_4117541.png",
        "date": "2026-07-23 10:11:14",
        "description": "Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 107.06",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs10706-4115237",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParmaxPharmaLtd_priceRelatedfactors_4115237.png",
        "date": "2026-07-22 10:39:09",
        "description": "From a 52-week low of Rs 22.60 to a new high of Rs 107.06, Parmax Pharma Ltd has surged an impressive 374% over the past year, significantly outpacing the Sensex’s decline of 6.54%. This remarkable rally is underpinned by a strong alignment of technical indicators and sustained price momentum, marking a notable milestone for the micro-cap pharmaceutical player."
      }
    ],
    "total": 176,
    "sid": "1002724",
    "stock_news_url": "https://www.marketsmojo.com/news/parmax-pharma-1002724"
  },
  "announcements": [
    {
      "caption": "Updates on Open Offer",
      "datetime": "29-Jul-2026",
      "details": "Fedex Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of newspaper publication of Offer Opening Pre-Offer Advertisement to the Public Shareholders of Parmax Pharma Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Updates on Open Offer",
      "datetime": "27-Jul-2026",
      "details": "Fedex Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of newspaper publication of Recommendations of the Committee of Independent Directors (IDC) to the Public Shareholders of Parmax Pharma Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Letter of Offer",
      "datetime": "22-Jul-2026",
      "details": "Fedex Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd (Target Company).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parmax Pharma Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals

2026-08-06 08:31:34

Parmax Pharma Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 5 August 2026, reflecting a complex interplay of deteriorating financial fundamentals, challenging valuation metrics, and mixed technical signals. Despite a robust stock price performance over the past year, the company’s underlying financial health and operational trends have raised significant concerns among analysts.

Read full news article

Parmax Pharma Gains 1.90%: 2 Key Milestones Mark a Week of Strong Momentum

2026-08-01 13:06:36

Key Events This Week

27 Jul: Stock opens week at Rs.104.87, gaining 1.98%

28 Jul: Continued gains to Rs.106.96 (+1.99%) despite Sensex dip

29 Jul: Stock rises to Rs.109.09 (+1.99%) with Sensex recovery

30 Jul: Parmax Pharma hits new 52-week and all-time high at Rs.111.27

31 Jul: Week closes at Rs.104.78, retreating 1.99% from peak

Week Open

Rs.102.83

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 111.27

2026-07-30 10:36:26

From a low of Rs 22.60 to a fresh peak of Rs 111.27, Parmax Pharma Ltd has surged an impressive 193.36% over the past year, significantly outperforming the Sensex which declined 4.77% in the same period. This remarkable rally culminated in the stock hitting a new 52-week and all-time high on 30 Jul 2026, fuelled by a confluence of strong technical signals and sustained price momentum.

Read full news article

Parmax Pharma Ltd Hits All-Time High of Rs 111.27 as Momentum Builds Across Timeframes

2026-07-30 10:32:37

Extending its winning streak to four consecutive sessions, Parmax Pharma Ltd surged 2.00% today to touch a fresh all-time high of Rs 111.27, significantly outpacing the Sensex which declined 0.15% in the same period.

Read full news article

Parmax Pharma Gains 1.90%: 5 Key Factors Driving the Week’s Momentum

2026-07-25 13:03:25

Key Events This Week

20 Jul: New 52-week and all-time high at Rs.102.92

21 Jul: Stock surged to Rs.104.97, marking another all-time high

22 Jul: New 52-week high of Rs.107.06 amid market weakness

23 Jul: Peak at Rs.109.20 before closing lower

24 Jul: Week closes at Rs.102.83, down 1.99% on the day

Week Open

Rs.100.91

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 109.2

2026-07-23 10:46:10

Surging to an all-time high of Rs 109.2 on 23 Jul 2026, Parmax Pharma Ltd has demonstrated remarkable momentum, rallying over 51% in the past 21 trading sessions. This micro-cap pharmaceutical stock’s ascent comes amid a broader market that remains subdued, with the Sensex trading slightly lower, underscoring the stock’s standout performance in its sector.

Read full news article

Parmax Pharma Ltd Hits All-Time High of Rs 109.20 as Momentum Builds Across Timeframes

2026-07-23 10:33:22

Extending a remarkable winning streak to 21 sessions, Parmax Pharma Ltd surged to a fresh all-time high of Rs 109.20 on 23 Jul 2026, outperforming the Sensex which declined 0.15% on the day. The stock’s 51.31% return over the past month and 222.79% year-to-date gain highlight a strong momentum that has captured market attention.

Read full news article

Parmax Pharma Ltd is Rated Sell

2026-07-23 10:11:14

Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 107.06

2026-07-22 10:39:09

From a 52-week low of Rs 22.60 to a new high of Rs 107.06, Parmax Pharma Ltd has surged an impressive 374% over the past year, significantly outpacing the Sensex’s decline of 6.54%. This remarkable rally is underpinned by a strong alignment of technical indicators and sustained price momentum, marking a notable milestone for the micro-cap pharmaceutical player.

Read full news article

View All News